Related Experiment Video
Updated: Jul 14, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
The promise of conjugate vaccines for Africa
Marie Paule Kieny1, F Marc LaForce
1Initiative for Vaccine Research, World Health Organization, Av Appia 20, 1211 Geneva 27, Switzerland. kienym@who.int
Insights
Conjugate vaccines for bacterial meningitis, like those for Neisseria meningitidis and Streptococcus pneumoniae, are effective. Optimizing their immunization schedules is crucial for maximizing herd immunity and disease prevention.
Area of Science:
- Vaccinology
- Immunology
- Microbiology
Background:
- Capsular polysaccharide (PS) vaccines against Neisseria meningitidis and Streptococcus pneumoniae are safe and effective.
- Chemical conjugation of PS to protein carriers significantly enhances vaccine immunogenicity, stimulating T and B cell responses, immunological memory, and herd immunity.
Purpose of the Study:
- To review evidence and analyze optimal immunization schedules for conjugate vaccines.
- To address the need for updated schedules that incorporate the role of herd immunity in disease transmission.
Main Methods:
- Literature review of existing evidence on conjugate vaccine immunogenicity and efficacy.
- Analysis of current World Health Organization recommended immunization schedules.
- Evaluation of the impact of herd immunity on disease transmission patterns.
Main Results:
- Conjugate vaccines induce robust T and B cell-dependent immune responses and immunological memory.
- The introduction of conjugate vaccines has significantly reduced the incidence of diseases caused by targeted bacterial pathogens.
- Current immunization schedules may not fully leverage the benefits of herd immunity.
Conclusions:
- Conjugate vaccines are highly effective in preventing bacterial diseases.
- Optimizing immunization schedules is essential for enhancing vaccine impact and achieving herd immunity.
- Further research and evidence review are warranted to refine conjugate vaccine schedules.
Abstract:
Capsular polysaccharide (PS) vaccines against Neisseria meningitidis and Streptococcus pneumoniae have proven safe and effective. Moreover, experience with N. meningitidis, Haemophilus influenzae type b (Hib) and S. pneumoniae conjugate vaccines has demonstrated that immunogenicity of PS vaccines can be greatly improved by chemical conjugation to a protein carrier. These vaccines have been shown to stimulate B cell- and T cell-dependent immune responses, to induce immunological memory and to confer herd immunity. Their introduction has had a dramatic impact on the incidence of the diseases caused by these bacterial pathogens, but questions remain on the optimal schedules for immunization. The current schedule recommended by the World Health Organization (6, 10 and 14 weeks) was developed in the early 1980s and does not take into consideration the crucial role of herd immunity in interrupting transmission. A review of the evidence in order to analyse how to optimize immunization schedules for conjugate vaccines is warranted.
More Related Videos
Related Concept Videos
Vaccine Production
Vaccines
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Vaccinations

